Showing 421 - 440 results of 19,773 for search '(( 50 ((ng decrease) OR (nn decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 0.71s Refine Results
  1. 421

    Genes whose expression was decreased in RASMC subjected to Na<sup>+</sup>,K<sup>+</sup>-ATPase inhibition. by Svetlana V. Koltsova (321381)

    Published 2014
    “…Given <i>in italics</i> are genes whose differential expression was detected in ischemic tissue by whole genome microarray-based analysis <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110597#pone.0110597-Mazzatti1" target="_blank">[12]</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110597#pone.0110597-Leonard1" target="_blank">[18]</a>. …”
  2. 422
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427

    EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

    Published 2011
    “…Arrows indicate lesion site. Scale bars in A–D, G,H, 100 µm; E,F, 50 µm.</p>…”
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433
  14. 434

    L-cysteine improves blood fluidity impaired by acetaldehyde: <i>In vitro</i> evaluation by Ippo Otoyama (6069815)

    Published 2019
    “…The blood passage time, percentage of microchannel obstruction, and numbers of adherent WBCs on the microchannel terrace increased after adding ACD in a concentration-dependent manner, whereas they decreased after adding ACD and L-cysteine in a L-cysteine concentration-dependent manner. …”
  15. 435
  16. 436
  17. 437
  18. 438
  19. 439

    Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial by Andreas Hartmann (241073)

    Published 2016
    “…We conducted a prospective, randomized double-blind study in 40 Parkinson disease patients at Hoehn & Yahr stages 1.5 to 3 who were either assigned to monthly bee venom injections or equivalent volumes of saline (treatment/placebo group: n = 20/20). …”
  20. 440